Cannabis sales in Nevada are expected to climb from $103 million in 2017 to $814 million by 2025, and these two companies want in on the action…

Nevada is the most important cannabis market in the world.

I’ve written that on a number of occasions. I mostly focus on Las Vegas because of its immense size, but the Reno market is also incredibly important – it’s basically a baby Vegas.

Las Vegas has about 40 million visitors each year, but Reno still brought in more than 5 million in 2018. The tourists visiting are looking to get away from their normal lives for a few days and are increasingly trying cannabis products during their vacations.

Cannabis tourism in Nevada is going to be a massive market, and the publicly traded cannabis companies that don’t already have a strong presence are realizing that they have to be there.

In the past couple of weeks, there have been two transactions that have validated the value of the Nevada market.

Today, I wanted to tell you how Cresco and iAnthus are getting their piece of the action…

Cresco’s Jump into the Nevada Markets

Cresco Labs Inc. (CSE: CL, OTC: CRLBF) purchased a company called Tryke, which operates the successful Reef dispensaries in the Las Vegas market.

This acquisition will turn Cresco into an important player in the Vegas market, moving the company to an 8% market share. In addition to the Reef dispensary – which is right behind the wildly successful Planet 13 Holdings Inc. (CSE: PLTH, OTC: PLNHF) store – Tryke operates a Reef location in North Las Vegas, which sees the highest traffic in the state.

It also has locations in Sparks and Sun Valley, which are both just outside of Reno.

As a bonus, Cresco gets locations in the Arizona market.

I’ll be writing a lot about Arizona in the coming months.

It’s a highly successful medical cannabis market with a high probability of allowing recreational use very soon. It’s similar to the booming Florida market, and public companies are taking notice. There will be a battle for Arizona, just as there is for Florida, and investors stand to profit if they understand the market.

If you’re ready for a chance to beat Wall Street, then you need access to our proprietary NICILytics database. Access to this tool gives you info on 190+ cannabis companies. Learn more now.

Cresco also got a license in Utah, but Nevada was the big news in the Cresco acquisition.

And Cresco paid a full and fair price for its assets – over $280 million. Private sellers don’t care that panicky retail investors have put the cannabis stock under pressure. If you want to buy their business, you have to pay full price.

What’s more, the sellers are taking the vast majority of their money in the form of Cresco stock; they believe it’s just as undervalued as I do.

iAnthus Hits Vegas

Not to be outdone, iAnthus Capital Holdings Inc. (CSE: IAN, OTC: ITHUF) followed Cresco with an acquisition in Northern Nevada.

iAnthus recently won four licenses for retail operations in Nevada to complement its existing cultivation operation, which currently sells to other dispensaries.

But those licenses are being held up by litigation in the state, and Nevada is too important of a market to wait around for the courts. iAnthus got proactive and bought its way into the market. It acquired a company called Sierra Well, which operates two dispensaries in Reno and Carson City.

Carson City is just to the south of Reno – drivers from the Bay Area in California can pass through on their way to Reno and it’s a tourist destination in its own right. The company also gets more cultivation space for its growing suite of brands that it sells to other dispensaries in the state.

iAnthus also paid up.

It’s paying $27 million for the acquisition.

And once again, the sellers didn’t want money. They’re taking over 80% of the purchase price in iAnthus shares.

These transactions should be instructive for public shareholders who have taken a beating this summer. The industry fundamentals are still intact, and companies are scrambling to position themselves in the most important market in the world because the branding thesis is so compelling.

And people who own their own cannabis companies are unwilling to sell at the levels the market is indicating now.

They’re waiting for the higher valuations to come.

Around this time next week, I’ll be sharing with our Cannabis Investor’s Report readers a complete who’s who for the Nevada market. Who is strong there, who is there but weak, who is in need of improvement, and who is on the outside looking in.

In that report, I’ll have some thoughts on how to play the Nevada market for maximum profits.

Greg Miller

Executive Director, National Institute for Cannabis Investors

P.S. Thanks to one landmark event in 2018, analysts predict sales in the hemp CBD sector will skyrocket to $22 billion by 2022… that’s a 3,622% jump in less than three years. With predictions like these, there’s no better time to get involved in CBD companies. And we’ve identified one breakout company that you can get started with for under $3 a share. For more info, just click here.


3 responses to “These Two Companies Want in on the Booming Nevada Market”


  2. Are we at or near a bottom for the stocks in the Model Portfolio? Or do you expect it to go lower? And is there a catalyst that you think might turn the market higher?

Leave a Reply

Your email address will not be published. Required fields are marked *